Skip to main content
. 2011 Apr 13;11(Suppl 3):S29. doi: 10.1186/1471-2458-11-S3-S29

Figure 5.

Figure 5

The results of Stage II CHNRI process – an expert opinion exercise assessing the potential usefulness of investment in multivalent meningococcal vaccines